Cell and Gene Therapy, Leadership October 04, 2023 RoslinCT to Present at 2023 Cell & Gene Meeting on the Mesa
Cell and Gene Therapy, Leadership October 03, 2023 RoslinCT Boston Appoints Dean J. Morris, as Chief Operations Officer
Cell and Gene Therapy, SAB August 17, 2023 RoslinCT Announces the Appointment of Dr. Derek Hei to its Scientific Advisory Board
Cell and Gene Therapy, Integration May 30, 2023 RoslinCT and Lykan Bioscience announce that the MHRA has granted an MIA License for their cGMP Manufacturing facilities in Edinburgh, UK